Company No: 08860655 (England and Wales)

Contents

• Balance Sheet
• Notes to the Financial Statements

		2026		2025
		£		£
Current assets		464,688		437,614
Prepayments and accrued income		569		541
Creditors: amounts falling due within one year		( 6,439)		( 5,872)
Net current assets		458,818		432,283
Total assets less current liabilities		458,818		432,283
Accruals and deferred income		( 2,916)		( 2,560)
Net assets		455,902		429,723
Capital and reserves		455,902		429,723

For the financial year ending 31 January 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
• These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
• These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Oxford Orthopaedic Technology Limited (registered number: 08860655) were approved and authorised for issue by the director on 25 May 2026 and were signed on its behalf by:

C Dodd Director

1. Employees

	2026		2025
	Number		Number
Monthly average number of persons employed by the Company during the financial year, including the director	1		1

2. Directors’ benefits: advances, credit and guarantees

Advances

During the year Dr Dodd owed Oxford Orthopaedic Technology Ltd £40,285 (2025 - £39.401). This amount is unsecured, repayable upon demand and has interest charged at 2.25% p.a.